V-Capital | Search

临床试验

计划入组 446 人

尚未招募

NCT07756801

CAPITAL OFFLOAD-SHOCK

计划入组 456 人 · 首次发布于 2026 年 8 月 11 日

Unknown

NCT03229590

Slipped Capital Femoral Epiphysis Treatment

计划入组 30 人 · 首次发布于 2017 年 7 月 25 日

药物

查看全部 414 →

V-934/V-935

Small Molecule

Approved

Phenoxymethylpenicillin(Pen VK)

生产企业：Eli lilly and co, Glaxosmithkline，另有 16 家

相关疾病：Actinomycosis, Animal bite，另有 16 项

C₁₆H₁₈N₂O₅S · Rx

V-404

机构

查看全部 137 →

UNIVERZA V MARIBORU

Slovenia

Hercules Capital

United States

Rand Capital

资讯

查看全部 3289 →

9个月前

Dyne Therapeutics Stock Plunges 17% Following $300 Million Secondary Offering Despite DMD Trial Success

11个月前

Ovid Therapeutics Secures $175M PIPE Financing to Advance CNS Drug Pipeline Through 2028

10个月前

临床试验

Capital Mãe

CAPITAL OFFLOAD-SHOCK

Slipped Capital Femoral Epiphysis Treatment

药物

V-934/V-935

Phenoxymethylpenicillin(Pen VK)

V-404

机构

UNIVERZA V MARIBORU

Hercules Capital

Rand Capital

资讯

Dyne Therapeutics Stock Plunges 17% Following $300 Million Secondary Offering Despite DMD Trial Success

Ovid Therapeutics Secures $175M PIPE Financing to Advance CNS Drug Pipeline Through 2028

TandemAI Secures $22M Series A Extension to Advance AI-Powered Drug Discovery Platform